Clinical trial

An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis…

NCT00092677 · Organon and Co, Industry · Completed

Key facts

NCT number NCT00092677
Title An Investigational Drug on Clinical Outcomes in Patients With Aortic Stenosis (Narrowing of the Major Blood Vessel of the Heart)(MK-0653A-043 AM4)(COMPLETED)
Official title A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effects of Ezetimibe + Simvastatin on Clinical Outcomes in Patients With Aortic Stenosis
Lead sponsor Organon and Co, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Aortic Stenosis
Intervention type Drug
Interventions ezetimibe (+) simvastatin, Comparator: Placebo
Enrollment 1,873
Start date Jan 1, 2001
Primary completion Apr 1, 2008
Completion Apr 1, 2008
First posted Sep 28, 2004
Last update posted May 16, 2024

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies